vimarsana.com
Home
Live Updates
Pfizer to Acquire Arena for $6.7B, Expanding Immuno-Inflammatory Pipeline : vimarsana.com
Pfizer to Acquire Arena for $6.7B, Expanding Immuno-Inflammatory Pipeline
Pfizer has agreed to acquire Arena Pharmaceuticals for approximately $6.7 billion, in a deal designed to expand the buyer’s immuno-inflammatory disease pipeline, led by Arena’s Phase II/II lead candidate etrasimod.
Related Keywords
Boston
,
Massachusetts
,
United States
,
San Diego
,
California
,
Switzerland
,
Bristol Myers Squibb Zeposia
,
Josephp Schwartz
,
Amitd Munshi
,
Mike Gladstone
,
Bristol Myers Squibb
,
Schwartz
,
Pfizer
,
Arena Pharmaceuticals
,
Pfizer Inflammation
,
Aristea Therapeutics
,
Park City
,
vimarsana.com © 2020. All Rights Reserved.